| Direct Dopamine Recording From Humans Engaging Working Memory |
Grant |
170,525.00 |
Research |
Robert Bina |
COM Phx Neurosurgery |
03/2024 |
| eNAMPT-Neutralizing Monoclonal Antibody (ALT-100), as a Novel Treatment of Chorioamnionitis |
Grant |
100,000.00 |
Research |
Mohamed Ahmed |
Pediatrics |
03/2024 |
| Enhancing Care Coordination for Asthma Management in Schools: A Collaborative Approach for Health Equity |
Grant |
12,000.00 |
Research |
Ashley Lowe |
Asthma/Airway Disease Rsch Ctr |
03/2024 |
| Family Medicine Residency Learning Community Planning Grant |
Grant |
5,000.00 |
Other Sponsored Activity |
Leah Hillier |
COM Phx Family Commun&Prev Med |
03/2024 |
| Gas Marbles for Delivery of Gases-as-Drugs |
Cooperative Agreement |
243,422.00 |
Research |
Frederic Zenhausern |
COM Phx Basic Medical Sci |
03/2024 |
| Global Health Equity Scholars Program |
Grant |
117,923.00 |
Research Training |
Purnima Madhivanan |
Global Health Institute |
03/2024 |
| Heparin-induced Thrombocytopenia Clinical Decision Support Dissemination and Implementation |
Contract |
196,975.00 |
Research |
Craig Heise |
COM Phx Internal Medicine |
03/2024 |
| Identification of a Male-Specific Mechanism of Nociceptor Sensitization Promoting Migraine in Active-Duty Service Members and Veterans |
Grant |
300,378.00 |
Research |
Caroline Kopruszinski |
Pharmacology |
03/2024 |
| Investigating the Role of Hepatic Glucagon Receptor Signaling in Healthspan and Aging |
Grant |
316,213.00 |
Research |
Jennifer Stern |
Medicine |
03/2024 |
| Modulation of Colonocyte Barrier Function and Signaling by Cytomegalovirus Infection |
Grant |
2,172,404.00 |
Research |
Jean Wilson |
Cellular & Molecular Medicine |
03/2024 |
| Psilocybin whole mushroom for the treatment of OCD: a randomized controlled double-masked trial to assess tolerability, safety, efficacy, and brain mechanisms of antiobsessional effects of psilocybin |
Grant |
975,739.00 |
Research |
Francisco Moreno |
Psychiatry |
03/2024 |
| Radioembolization Oncology Trial Utilizing Transarterial Eye90 (ROUTE 90) for the Treatment of Hepatocellular Carcinoma (HCC) |
Contract |
930,247.28 |
Clinical Trial |
Shamar Young |
Cancer Center Division |
03/2024 |
| Resilience Informatics for Public Health in Central America |
Grant |
50,000.00 |
Research |
Madurai Iyengar |
COM Phx Internal Medicine |
03/2024 |
| SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study |
Contract |
186,453.12 |
Clinical Trial |
Wei Zhou |
Surgery |
03/2024 |
| Statistical Methods and Software for Multivariate Meta-analysis |
Grant |
44,495.00 |
Research |
Lifeng Lin |
Epidemiology and Biostatistics |
03/2024 |
| Structural Dynamics of Cardiac Myosin-Binding Protein C Regulation |
Grant |
2,459,004.00 |
Research |
Brett Colson |
Cellular & Molecular Medicine |
03/2024 |
| Validation of Targeting the FAK FAT Domain in Cancer |
Contract |
42,355.00 |
Research |
Timothy Marlowe |
COM Phx Internal Medicine |
03/2024 |
| Work Order to the Master Subaward Agreement for Non-industry Funding Sourcesbetween the Children's Hospital of Philadelphia (CHOP) Contracting on Behalf of the Children's Oncology Group (COG) |
Cooperative Agreement |
750,000.00 |
Clinical Trial |
Holly Pariury |
Cancer Center Division |
03/2024 |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ficlatuzumab in Combination with Cetuximab in Participants with Recurrent or Metastatic (R/M) HPV-Negative Head and Neck S |
Contract |
119,770.80 |
Clinical Trial |
Ricklie Julian |
Cancer Center Division |
02/2024 |
| A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Compared to R2 in Subjects with Relapsed or Refractory Follicular Lymphom |
Contract |
1,246,360.61 |
Clinical Trial |
Abhijeet Kumar |
Cancer Center Division |
02/2024 |
